Rory Riggs is the Founder and CEO of Locus Analytics, an economic research firm developing a new systems model to locate, map, and study the components of an economy. Rory is also the chairman and co-founder of Royalty Pharma, the largest investor in revenue-producing intellectual property; principally, royalty interests in marketed and late-stage development biopharmaceutical products. In addition, Rory is Chairman and co-founder of Cibus, the leader in non-transgenic plant breeding: its technology is enabling a new precision gene editing approach to plant breeding that promises to move the food industry beyond current GMO (or transgenic) technologies.

During his career, Rory has been involved in the creation and management of many successful technology-related companies including: Royalty Pharma; Fibrogen, Inc.; Cibus, LLC; Sugen, Inc.; and, eReceivables, Inc. He served as the president and director of Biomatrix Corporation (NYSE: BXM) from 1995 until its sale to Genzyme Corporation in December 2000. Rory oversaw the global launch of Biomatrix’s lead product, Synvisc. Rory received a BA from Middlebury College and an MBA from Columbia University.